Phase II trial of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Jun 2015
At a glance
- Drugs Bevacizumab; Gemcitabine; Oxaliplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2009 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Additional lead trial investigator identified, actual patient number (45) added as reported by ClinicalTrials.gov.